<unk>  is a urease inhibitor, urinary stone agent that is FDA approved for the treatment of adjunctive therapy in patients with chronic urea-splitting urinary infection, to decrease urinary ammonia and alkalinity, but it should not be used in lieu of curative surgical treatment (for patients with stones) or antimicrobial treatment. Long-term treatment with<unk>  may be warranted to maintain urease inhibition as long as urea-splitting infection is present. Children with chronic, recalcitrant, urea-splitting urinary infection may benefit from treatment with<unk> ..   Common adverse reactions include loss of appetite, nausea, vomiting and headache..
Acetohydroxamic Acid
Iodoxamic acid
Gadoteric acid
Iocetamic acid
Edetate disodium
Aminocaproic acid 
Elosulfase alfa
Aprotinin